Notes to Accounts:
1. Segment Reporting:
Based on the guiding principles given in Accounting Standard on Segment Reporting (AS -17) issued by the Institute of Chartered Accountants of India the company's primary business segment is Formulations. During the period your company has achieved a turnover of Rs 3285.54 lacs for Formulations & Feed Supplement.
2 Investment in Total Health Kare International Private Limited subsidiary of Celestial Biolabs Ltd of
Rs. 30.10 Lakhs
4) Paise have been rounded off to the nearest Rupee.
5) On applicability of revised Schedule II from current year, the Company has reclassified previous year figures to conform to this year's classification. The adoption of revised Schedule II does not impact recognition and measurement principles followed for preparation of the financial statements. However, it significantly impacts presentation and disclosures made in the financial statements, particularly presentation of Balance Sheet.
6).Balance in respect of creditors, Various Advances, Sundry Debtors are subject to confirmation from the respective parties.
7).As the company has not in the possession of information regarding dues to the Micro, Small and Medium Enterprises, the same has not been furnished herewith.
8). Additional Information required under Part II of Schedule V to the Companies Act 2013.
a) Capacities and Production
Product Unit Installed capacity / Actual Production Not Applicable
Licensed Capacity Not Applicable
|